These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34918991)

  • 1. Pure and Mixed Tubular Carcinoma of the Breast: Mammographic Features, Clinicopathological Characteristics and Prognostic Analysis.
    Wen C; Xu W; Qin G; Zeng H; He Z; Wang S; Xu Z; Ma M; Luo Z; Chen W
    Technol Cancer Res Treat; 2021; 20():15330338211045198. PubMed ID: 34918991
    [No Abstract]   [Full Text] [Related]  

  • 2. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
    Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
    Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is complete axillary lymph node dissection neccessary in T1 stage invasive pure tubular carcinomas of the breast?
    Fernández-Aguilar S; Simon P; Buxant F; Fayt I; Nöel JC
    Breast; 2005 Aug; 14(4):325-8. PubMed ID: 16085240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
    Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
    [No Abstract]   [Full Text] [Related]  

  • 7. Predicting axillary sentinel node status in patients with primary breast cancer.
    Kolarik D; Pecha V; Skovajsova M; Zahumensky J; Trnkova M; Petruzelka L; Halaska M; Sottner O; Otcenasek M; Kolarova H
    Neoplasma; 2013; 60(3):334-42. PubMed ID: 23374005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure tubular carcinoma of the breast and sentinel lymph node biopsy: a retrospective multi-institutional study of 234 cases.
    Dejode M; Sagan C; Campion L; Houvenaeghel G; Giard S; Rodier JF; Ferron G; Jaffre I; Levêque J; Bendavid C; Dravet F; Marchal F; Bordes V; Faure C; Tunon de Lara C; Classe JM
    Eur J Surg Oncol; 2013 Mar; 39(3):248-54. PubMed ID: 23273874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
    Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
    Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual lymph node tumour burden following removal of a single axillary sentinel lymph with macrometastatic disease in women with screen-detected invasive breast cancer.
    Dave RV; Cheung S; Sibbering M; Kearins O; Jenkins J; Gandhi A
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33688940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic features predicting involvement of non- sentinel axillary lymph nodes in Iranian women with breast cancer.
    Moosavi SA; Abdirad A; Omranipour R; Hadji M; Razavi AE; Najafi M
    Asian Pac J Cancer Prev; 2014; 15(17):7049-54. PubMed ID: 25227789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubular carcinoma of the breast: an institutional review.
    McBoyle MF; Razek HA; Carter JL; Helmer SD
    Am Surg; 1997 Jul; 63(7):639-44; discussion 644-5. PubMed ID: 9202540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of predictive factors affecting sentinel lymph node status in early breast cancer patients].
    Jiao D; Qiao J; Lu Z; Li L; Zhang H; Liu H; Cui S; Liu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):198-201. PubMed ID: 24785280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel Node Biopsy in Early Breast Cancer Patients with Palpable Axillary Node.
    Shojaee L; Abedinnegad S; Nafisi N; Naghshvar F; Godazandeh G; Moradi S; Shakeri Astani K; Godazandeh Y
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1631-1636. PubMed ID: 32592357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeat sentinel lymph node biopsy in patients with ipsilateral recurrent breast cancer after breast-conserving therapy and negative sentinel lymph node biopsy: a prospective study.
    Folli S; Falco G; Mingozzi M; Buggi F; Curcio A; Ferrari G; Taffurelli M; Regolo L; Nanni O
    Minerva Chir; 2016 Apr; 71(2):73-9. PubMed ID: 26207566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile?
    Ugras S; Matsen C; Eaton A; Stempel M; Morrow M; Cody HS
    Ann Surg Oncol; 2016 Mar; 23(3):744-8. PubMed ID: 26644258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Well-differentiated (tubular) carcinoma of the breast. A clinicopathologic study of 145 pure and mixed cases.
    Deos PH; Norris HJ
    Am J Clin Pathol; 1982 Jul; 78(1):1-7. PubMed ID: 6285690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.